This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The first edition of this book was published in July 1965. Over 30,000 copies were sold within the first six months and the AMA had to order two extra printings. The second (1966) edition has been enlarged and improved by the addition of five new chapters and 30 new drug monographs. Many of the individual drug evaluations have been revised, as have some of the general discussions which review the older drugs at the beginning of each chapter.
New Drugs contains individual monographs on 290 single-entity products that have been marketed in the United States within the last ten years. Each monograph gives information on the drug's actions and uses, adverse reactions, contraindications or precautions, dosage and routes of administration, and preparations and their available sizes and strengths. These brief and clearly written statements provide the practicing physician with an independent and unbiased assessment of the more recently introduced drugs.
SMITH HD. New Drugs: Evaluated by the AMA Council on Drugs. Am J Dis Child. 1966;112(1):93–94. doi:10.1001/archpedi.1966.02090100129024
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: